Type II atrial flutter interruption with transesophageal pacing: Use of propafenone and possible change of the substrate

PACE - Pacing and Clinical Electrophysiology

Volumn 19, Issue 11 II, 1996, Pages 1958-1961

  Doni, Flavio ^b   Staffiere, Elio ^b   Manfredi, Margherita ^b   Piemonti, Carlo ^b   Todd, Sarah ^b   Rimondini, Andrea ^b   Fiorentini, Cesare ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Policlinico San Pietro   (Italy)

Author keywords

atrial flutter; propafenone; transesophageal pacing

Indexed keywords

PROPAFENONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HUMAN; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029859053     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1996.tb03261.x     Document Type: Article

References (19)

1. Waldo AL, Henthorn RW, Plump VJ. Atrial flutter. Recent observations in man. In ME Josephson, HJJ Wellens (eds.): Tachycardias: Mechanisms, Diagnosis, Treatment. Philadelphia, Lea & Febiger, 1984, pp. 113-135.
2. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia, III: The leading circle concept: A new model of circus movement in cardiac tissue without the involvement of an anatomic obstacle. Circ Res 1977; 41:9-18.
3. Kingma JH, Suttorp MJ. Acute pharmacological conversion of atrial fibrillation and flutter: The role of flecainide, propafenone and verapamil. Am J Cardiol 1992; 70:56A-61A.
4. Klein GJ, Guiraudon GM, Sharma AD, et al. Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol 1986; 57:587-591.
5. Smeets J, Allessie MA, Lammers W, et al. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. Circ Res 1986; 58:96-108.
6. Waldo AL, MacLean WAH, Karp RB, et al. Entrainment and interruption of atrial flutter with atrial pacing. Studies in man following open heart surgery. Circulation 1977; 56:737-745.
7. Wells JL, MacLean WAH, James TN, et al. Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes. Circulation 1979; 60:665-673.
8. Disertori M, mama G, Vergara G, et al. Evidence of a reentry circuit in the common type of atrial flutter in man. Circulation 1983; 67:434-440.
9. Watson JL, Josephson ME. Atrial flutter. I. Electrophysiologic substrates and modes of initiation and termination. Am J Cardiol 1980; 45:732-741.
10. Inoue H, Matsou H, Takayanagi K, et al. Clinical and experimental studies of the effects of atrial extrastimulation and rapid pacing on atrial flutter cycle. Evidence of macroreentry with an excitable gap. Am J Cardiol 1981; 48:623-631.
11. Boineau JP. Atrial flutter: A synthesis of concepts. Circulation 1985; 72:249-257.
12. Ravelli F, Disertori M, Cozzi F, et al. Ventricular beats induce variations in cycle length of rapid (type II) atrial flutter in humans. Circulation 1994; 89:2107-2116.
13. Falk RH, Werner M. Transesophageal atrial pacing using a pill electrode for the termination of atrial flutter. Chest 1987; 92:110-114.
14. Chung DC, Kerr CR, Cooper J. Termination of spontaneous atrial flutter by transesophageal pacing. PACE 1987; 10:1147-1153.
15. Crawford W, Plumb VJ, Epstein AE, et al. Prospective evaluation of transesophageal pacing for the interruption of atrial flutter. Am J Med 1989; 86:663-667.
16. Guarnerio M, Furlanello F, Del Greco M, et al. Transesophageal atrial pacing: A first choice technique in atrial flutter therapy. Am Heart J 1989; 117:1241-1252.
17. Tucker KJ, Wilson C. A comparison of transesophageal atrial pacing and direct current cardioversion for the termination of atrial flutter: A prospective, randomised clinical trial. Br Heart J 1993; 69:530-535.
18. Kantharia BK, Mookherjee S. Clinical utility and the predictors of outcome of overdrive transesophageal atrial pacing in the treatment of atrial flutter. Am J Cardiol 1995; 76:144-147.
19. Doni F, Delia Bella P, Kheir A, et al. Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone. Am J Cardiol 1995; 76:1243-1246.